Document is current
Any future updates will be listed below
-
Authors
Ge, Yunhui https://orcid.org/0000-0002-0345-5532
de Almeida Magalhaes, Taciani https://orcid.org/0000-0002-6743-1003
Wu, Hongjiang
van den Boomen, Dick J. H. https://orcid.org/0000-0001-6474-3661
Nguyen, Thu Uyen
Dou, Tongyi https://orcid.org/0000-0002-4252-5038
Yadav, Gaya P. https://orcid.org/0000-0002-4514-4679
Lee, Sukyeong https://orcid.org/0000-0001-6054-6628
Wang, Zhao https://orcid.org/0000-0003-4897-9986
Lemoff, Andrew https://orcid.org/0000-0002-4943-0170
Luo, Xuemei
Menon, Sumitha S.
Zhang, Min
Wang, Jin https://orcid.org/0000-0003-3625-7919
Jin, Zhicheng
Jiang, Jiansen https://orcid.org/0000-0002-1692-7906
Salic, Adrian
Huang, Pengxiang https://orcid.org/0000-0001-7811-5017
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences (R01GM150878)
Cancer Prevention and Research Institute of Texas (RR200080)
- License Information
-
More Information
Article History
Received: 10 January 2026
Accepted: 3 June 2026
First Online: 19 June 2026
Competing interests
: J.W. is the founder of Chemical Biology Probes LLC. J.W. has stock ownership in CoRegen Inc and serves as a consultant for this company. J.W. is also a co-founder of Fortitude Biomedicines, Inc. and holds equity interest in this company. None of these competing interests is relevant to this study. The remaining authors declare no competing interests.
